Clin Osteol 2010; 15(3): 92-94

Increased serum parathyroid hormone concentration with normal serum calcium levels in patients operated for primary hyperparathyroidismReview articles

O. Nývltová, D. Nováková

The article is concerned with the etiology of a postoperative increase in serum parathyroid hormone (PTH) level in patients success­ fully operated for primary hyperparathyroidism (HPT) who have normal postoperative calcium levels. Most authors agree on this being secondary HPT due to hypovitaminosis D and hungry bone syndrome [1]. It is contributed to by metabolic primary HPT and restricted calcium intake in the preoperative period, resulting in skeletal demineralization. Other works, however, relate secondary HPT in p bone metabolism markers, bone density and race. Recurrent and persistent hyperparathyroidism account for approximately 1-2 % of cases and are not dealt

Keywords: parathyroid hormone, primary hyperparathyroidism, secondary hyperparathyroidism, hypovitamino­ sis D, parathyroidectomy, normocalcemic hyperparathormonemia

Published: December 11, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nývltová O, Nováková D. Increased serum parathyroid hormone concentration with normal serum calcium levels in patients operated for primary hyperparathyroidism. Osteologický bulletin. 2010;15(3):92-94.
Download citation

References

  1. Silverberg SJ. Vitamin D Defi Miner Res 2007; 22:S2;V100/V104. Go to original source...
  2. Bergenfelz A, Valdemarsson S, Tibblin S. Persistent elevated serum levels of tact parathyroid hormone after operation for sporadic parathyroid adenoma: evi­ dence of detrimental effects of severe parathyroid disease. Surgery 1996;119(6): 624-633. Go to original source...
  3. Beyer TD, Solorzano CC, Prinz RA et al. Oral vitamin D supplementation redu­ ces the incidence of eucalcemic PTH elevation after surgery for primary hyperpa­ rathyroidism. Surgery 2007;141(6):777-83. Epub 2007 Apr 2. Go to original source...
  4. Denizot A, Pucini M, Chagnaud C et al. Normocalcemia with elevated para hormone levels after surgical treatment of primary hyperparathyroidism. Am J Surg 2001;182(1):15-19. Go to original source...
  5. Wang TS. Persistently elevated pa gery. Surgery 2005;138(6):1130-1135. Go to original source...
  6. Nordenstrom E, Westerdahl J, Bergenfelz A Long-term follow-up of patients w elevated PTH levels following successful exploration for primary hyperparathy­ roidism. World J Surg 2004;28(6):570-575. Go to original source...
  7. Carty SE, Roberts MM, Virji MA, Haywood L, Yim JH. Elevated serum parat­ hormone level after "concise parathyroidectomy" for primary sporadic hyperpa­ rathyroidism. Surgery 2002;132(6):1086-1092. Go to original source...
  8. Dhillon KS, Cohan P, Darwin C, Van Herle A, Chopra IJ. Elevated serum para­ thyroid hormone concentration in eucalcemic patients after parathyroid primary hyperparathyroidism and its relationship to vitamin D profile. Metabolism 2004;53(9):1101-1106. Go to original source...
  9. Mittendorf EA, McHenry CR. Persistent parathyroid hormone elevation follo curative parathyroidectomy for primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg 2002;128(3):275-279. Go to original source...
  10. Westerdahl J, Valdemarsson S, Lindblom P, Bergenfelz A Postoperative elevated serum levels of intact parathyroid hormone after surgery for parathyroid adeno sign of bone remineralization and decreased calcium absorption. World J Surg 2000;24(11):1323-1329. Go to original source...
  11. Mandal AK, Udelsman R. Secondary hyperparathyroidism is an expected conse­ quence of parathyroidectomy for pr dy. Surgery 1998;124(6):1021-1026. Go to original source...
  12. Abugassa S, Nordenstrom J, Eriksson S at al. Skeletal remineralizatio gery for primary and secondary hyperparathyroidism. Surgery 1990; 107(2): 128-133.
  13. Moosgaard B, Vestergaard P, Heickendorff L et al. Vitamin D status, season riations, parathyroid adenoma weight and bone mineral density in primary hyper parathyroidism. Clinical endocrinology 2005;63:506-513. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.